Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 7(1): e29704, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22235330

RESUMEN

Leaf characters have been successfully utilized to classify Camellia (Theaceae) species; however, leaf characters combined with supervised pattern recognition techniques have not been previously explored. We present results of using leaf morphological and venation characters of 93 species from five sections of genus Camellia to assess the effectiveness of several supervised pattern recognition techniques for classifications and compare their accuracy. Clustering approach, Learning Vector Quantization neural network (LVQ-ANN), Dynamic Architecture for Artificial Neural Networks (DAN2), and C-support vector machines (SVM) are used to discriminate 93 species from five sections of genus Camellia (11 in sect. Furfuracea, 16 in sect. Paracamellia, 12 in sect. Tuberculata, 34 in sect. Camellia, and 20 in sect. Theopsis). DAN2 and SVM show excellent classification results for genus Camellia with DAN2's accuracy of 97.92% and 91.11% for training and testing data sets respectively. The RBF-SVM results of 97.92% and 97.78% for training and testing offer the best classification accuracy. A hierarchical dendrogram based on leaf architecture data has confirmed the morphological classification of the five sections as previously proposed. The overall results suggest that leaf architecture-based data analysis using supervised pattern recognition techniques, especially DAN2 and SVM discrimination methods, is excellent for identification of Camellia species.


Asunto(s)
Camellia/anatomía & histología , Camellia/clasificación , Reconocimiento de Normas Patrones Automatizadas/métodos , Hojas de la Planta/anatomía & histología , Hojas de la Planta/clasificación , Análisis por Conglomerados , Redes Neurales de la Computación
2.
J Biol Chem ; 276(50): 46707-13, 2001 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-11590169

RESUMEN

Transforming growth factor-beta (TGF-beta) can induce epithelial to mesenchymal transdifferentiation (EMT) in mammary epithelial cells. TGF-beta-mediated EMT involves the stimulation of a number of signaling pathways by the sequential binding of the type II and type I serine/threonine kinase receptors, respectively. Integrins comprise a family of heterodimeric extracellular matrix receptors that mediate cell adhesion and intracellular signaling, hence making them crucial for EMT progression. In light of substantial evidence indicating TGF-beta regulation of various beta(1) integrins and their extracellular matrix ligands, we examined the cross-talk between the TGF-beta and integrin signal transduction pathways. Using an inducible system for the expression of a cytoplasmically truncated dominant negative TGF-beta type II receptor, we blocked TGF-beta-mediated growth inhibition, transcriptional activation, and EMT progression. Dominant negative TGF-beta type II receptor expression inhibited TGF-beta signaling to the SMAD and AKT pathways, but did not block TGF-beta-mediated p38MAPK activation. Interestingly, blocking integrin beta(1) function inhibited TGF-beta-mediated p38MAPK activation and EMT progression. Limiting p38MAPK activity through the expression of a dominant negative-p38MAPK also blocked TGF-beta-mediated EMT. In summary, TGF-beta-mediated p38MAPK activation is dependent on functional integrin beta(1), and p38MAPK activity is required but is not sufficient to induce EMT.


Asunto(s)
Ecdisterona/análogos & derivados , Integrina beta1/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Transducción de Señal , Factor de Crecimiento Transformador beta/metabolismo , Adhesión Celular , Diferenciación Celular , Citoplasma/metabolismo , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Ecdisterona/farmacología , Activación Enzimática , Células Epiteliales/enzimología , Células Epiteliales/metabolismo , Matriz Extracelular/metabolismo , Genes Dominantes , Immunoblotting , Ligandos , Mesodermo/citología , Mesodermo/metabolismo , Microscopía Fluorescente , Proteínas Quinasas Activadas por Mitógenos/genética , Fenotipo , Fosforilación , Pruebas de Precipitina , Unión Proteica , Proteínas Serina-Treonina Quinasas , Receptor Tipo II de Factor de Crecimiento Transformador beta , Receptores de Factores de Crecimiento Transformadores beta/genética , Receptores de Factores de Crecimiento Transformadores beta/metabolismo , Espectrometría de Fluorescencia , Factores de Tiempo , Activación Transcripcional , Proteínas Quinasas p38 Activadas por Mitógenos
3.
Mol Biol Cell ; 12(1): 27-36, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11160820

RESUMEN

Transforming growth factor-beta1 (TGF-beta) can be tumor suppressive, but it can also enhance tumor progression by stimulating the complex process of epithelial-to-mesenchymal transdifferentiaion (EMT). The signaling pathway(s) that regulate EMT in response to TGF-beta are not well understood. We demonstrate the acquisition of a fibroblastoid morphology, increased N-cadherin expression, loss of junctional E-cadherin localization, and increased cellular motility as markers for TGF-beta-induced EMT. The expression of a dominant-negative Smad3 or the expression of Smad7 to levels that block growth inhibition and transcriptional responses to TGF-beta do not inhibit mesenchymal differentiation of mammary epithelial cells. In contrast, we show that TGF-beta rapidly activates RhoA in epithelial cells, and that blocking RhoA or its downstream target p160(ROCK), by the expression of dominant-negative mutants, inhibited TGF-beta-mediated EMT. The data suggest that TGF-beta rapidly activates RhoA-dependent signaling pathways to induce stress fiber formation and mesenchymal characteristics.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Mesodermo/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología , Proteína de Unión al GTP rhoA/farmacología , Animales , Células Epiteliales/citología , GTP Fosfohidrolasas/farmacología , Humanos , Péptidos y Proteínas de Señalización Intracelular , Mesodermo/citología , Ratones , Visón , Proteínas Serina-Treonina Quinasas/efectos de los fármacos , Transducción de Señal , Transfección , Factor de Crecimiento Transformador beta1 , Células Tumorales Cultivadas , Quinasas Asociadas a rho , Proteína de Unión al GTP rhoA/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA